1. Market Research
  2. > Pharmaceutical Market Trends

Indian Peptides and Heparin Market by Type, Application - Forecast to 2022

  • August 2017
  • 77 pages
  • MarketsandMarkets
Report ID: 5077133

Summary

Table of Contents

Search Inside

“Indian Peptides and Heparin Market projected to grow at a CAGR of 15.0% and 4.9% respectively”
The Indian peptides market is expected to reach USD 883.0 million in 2022 from USD 381.8 million in 2016 and is expected to register a CAGR of 15.0%, and the Indian heparin market is projected to reach USD 170.2 million by 2022, at a CAGR of 4.9%. Factors such as increasing prevalence of chronic diseases, increasing incidence of coagulation disorder, and favorable government policies are the major driving factors for the Indian peptides and heparin market. On the other hand, the availability of alternative drugs is the major restraining factor for the Indian peptides market. The patent expiry of blockbuster drugs will provide growth opportunities to players in the Indian peptides market. For example, Victorza is the brand name of the liraglutide peptide developed by Novo Nordisk. Its patent will expire in August 2017, which will enable drug manufacturers to introduce their generic versions of it.

“Bivalirudin type is expected to register the highest growth during the forecast period”
The Indian peptides market is classified on the basis of type into insulin, teriparatide, liraglutide, glucagon, leuprolide acetate, octreotide acetate, calcitonin salmon, triptorelin, eptifibatide, glatiramer acetate, bivalirudin, exenatide, and other molecules. The bivalirudin segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to the increasing number of percutaneous coronary intervention procedures (PCI) in India.

“Awareness about early diagnosis drives growth of the diabetes segment”
By application, the Indian peptides market is segmented into diabetes, infectious disease, cancer, cardiology, osteoporosis, gynecological applications, and other applications. The diabetes segment is expected to register highest CAGR during the forecast period. The growth in this segment can be primarily attributed to increasing awareness of early diagnosis, increasing prevalence & incidence of diabetes, and increasing aging population.
Key players operating in the Indian peptides market include Abbott Laboratories (U.S.), Sanofi S.A. (France), Eli Lilly and Company (U.S.), Cipla Limited (India), Biocon Limited (India), Intas Pharmaceuticals Ltd. (India), Sun Pharmaceutical Industries Ltd. (India), Cadila Pharmaceuticals (India), Lupin Limited (India), Emcure Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Dr. Reddy’s Laboratories Limited (India), and Alkem Laboratories Limited (India).

“Enoxaparin sodium type is expected to register the highest growth during the forecast period”
The Indian heparin market is classified on the basis of type into enoxaparin sodium, heparin sodium, fondaparinux, and dalteparin sodium. The enoxaparin sodium type segment is expected to register the highest growth during the forecast period. This growth can be attributed to the increasing coagulation disorders in the country.
Key players operating in the Indian heparin market include Sanofi (France), Emcure Pharmaceutical Pvt. Ltd. (India), Cipla Ltd. (India), Bharat Serum (India), Pfizer Inc. (U.S.), Abbott Laboratories (U.S.), Lupin Ltd. (India), Dr. Reddy’s Laboratories (India), Intas Pharmaceuticals Ltd. (India), Samarth Life Sciences (India), Claris Lifesciences Limited (India), Gland Pharma Limited (India), Mylan Pharmaceutical (India), Torrent Pharmaceuticals (India), Micro Labs Ltd. (India), and VHB Lifesciences (India).

The primary interviews conducted for this report can be categorized as follows:
• By Company Type - Tier 1 – 70 %, Tier 2 – 30%
• By Designation – C level – 62%, Director level – 21%, Others – 17%

Research Coverage:
The report analyses the Indian peptides market by type and application and the Indian heparin market by type. Apart from comprehensive product analysis and market sizing, the report also provides the complete list of peptide and heparin manufacturers and marketing players in India. In addition, the report profiles companies with product portfolios and key financial data by key players to maintain and increase their shares in the market. The abovementioned market research data, market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions to be successful in the market.

Benefits of Buying this Report:
This report will enable both established firms as well as new entrants/smaller firms gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the five strategies mentioned below to strengthen their market shares.

The report provides insights on the following strategies:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the Indian peptides and heparin market. The report analyses the Indian peptides market by type and application and the Indian heparin market by type.
• Competitive Assessment: In-depth assessment of the market strategies, business segments, and product portfolios of the leading players in the Indian peptides and heparin market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Pharmaceutical, Laboratory and Hygienic Glassware Markets in the World to 2021 - Market Size, Trends, and Forecasts

  • $ 26587
  • Industry report
  • July 2017
  • by Global Research & Data Services

This industry report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for pharmaceutical, laboratory and hygienic glassware in the world. Along ...

OpportunityAnalyzer: Acute Myeloid Leukemia - Opportunity Analysis and Forecasts to 2026

  • $ 10995
  • Industry report
  • July 2017
  • by GlobalData

OpportunityAnalyzer: Acute Myeloid Leukemia - Opportunity Analysis and Forecasts to 2026 Summary Acute myeloid leukemia (AML) is a rapidly progressing blood cancer with a poor overall prognosis. AML is ...

Pharmaceutical, Laboratory and Hygienic Glassware Markets in Europe to 2021 - Market Size, Trends, and Forecasts

  • $ 12622
  • Industry report
  • July 2017
  • by Global Research & Data Services

This industry report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for pharmaceutical, laboratory and hygienic glassware in different European ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.